Safest Antidepressants During Lactation

Key Principle

First-Choice Agents (Preferred)

1. Sertraline (Zoloft) - TOP CHOICE

• Has one of the largest evidence bases for use during breastfeeding.
• Relative Infant Dose (RID) is consistently <2% of the weight-adjusted maternal dose - well below the commonly cited 10% safety threshold.
• Infant plasma levels are negligible or undetectable in most studies.
• No clinically significant adverse effects have been reliably reported in breastfed infants.
• Preferred first-line by the Maudsley Prescribing Guidelines, Kaplan & Sadock's, and Canadian clinical practice guidelines.

2. Paroxetine (Paxil)

• Also has a large evidence base and among the lowest milk transfer rates.
• RID typically <2%; infant plasma levels negligible or undetectable.
• Caveat: Generally avoided in women planning a future pregnancy (associated with a ~2x risk of cardiac septal defects in first-trimester exposure). For lactation only, it is considered a preferred agent alongside sertraline.
• Note: Paroxetine is only indicated in menopausal females in some contexts (e.g., for vasomotor symptoms); when used for depression in a breastfeeding mother, it is acceptable.

Second-Choice Agents (Acceptable with monitoring)

3. Nortriptyline (TCA)

• Lowest milk/plasma ratio among the tricyclics.
• RID generally low; infant levels typically undetectable.
• May use during breastfeeding; infants should be monitored for sedation and anticholinergic effects.
• A reasonable choice when SSRIs are not tolerated or when the mother was already responding to it.

4. Amitriptyline / Imipramine / Desipramine (TCAs)

• All categorized as "may use during breastfeeding - low risk of infant harm based on drug properties and limited human studies" (Yamada's Gastroenterology).
• Less preferred than sertraline/paroxetine due to anticholinergic side effects and sedation.

5. Citalopram / Escitalopram

• Present in breast milk at intermediate levels (higher than sertraline/paroxetine, lower than fluoxetine).
• High doses of citalopram should be used with caution.
• Escitalopram's active demethyl metabolite is also detectable in milk - monitor infant for unwanted effects.
• Acceptable if the mother has previously responded well, but not a first choice.

Agent to Avoid: Fluoxetine (Prozac)

• NOT recommended as a first choice when starting an antidepressant postpartum.
• Fluoxetine and its active metabolite norfluoxetine have very long half-lives (1-2 weeks for norfluoxetine), leading to accumulation in the breastfed infant.
• Associated short-term adverse effects in infants include: colic, seizures, irritability, withdrawal symptoms, and cyanosis.
• Premature infants or those with hepatic immaturity are especially vulnerable.
• Exception: If a mother was already successfully treated with fluoxetine during pregnancy, continuing it postpartum may be reasonable (switching introduces a new exposure).

Summary Table

Practical Points

• Breastfeeding should not be prohibited simply because a mother needs an antidepressant. The benefits of breastfeeding and treating maternal depression outweigh the pharmacologic risk to the infant in almost all cases.
• If a drug was used during pregnancy, it is reasonable to continue the same agent during lactation rather than switching - the infant is already acclimatized to it, and switching introduces an unknown.
• Premature infants and those with hepatic impairment need closer monitoring regardless of which agent is used.
• Monitor the infant for: irritability, poor feeding, poor sleep, excessive sedation, or unusual weight patterns.